Tasmar and aortic valve sclerosis Patient Reports February 13, 2012

Tasmar Side Effects Report #4621109-3
Tasmar side effect was reported by a Physician from on Feb 15, 2005. Male patient, 60 years of age, was diagnosed with parkinson's disease  and was treated with Tasmar. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, hepatic enzyme increased. Tasmar dosage: 100 MG; 3 TIMES A DAY; ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, CARBIDOPA AND LEVODOPA, AMANTADINE DULFATE, NACOM, PERGOLIDE MESYLATE, CARBIDOPA AND LEVODOPA, AMANTADINE SULPHATE, COMITESS. Patient was hospitalized. Patient recovered.

Tasmar Side Effects Report #4639099-6
Tasmar side effect was reported by a Physician from on Apr 08, 2005. Male patient, 60 years of age, was diagnosed with parkinson's disease  and was treated with Tasmar. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, bronchitis acute, hepatic enzyme increased. Tasmar dosage: 100 MG; 3 TIMES A DAY; ORAL; SEE IMAGE. During the same period patient was treated with PERGOLIDE MESYLATE, CARBIDOPA AND LEVODOPA, AMANTADINE SULPHATE, COMTESS, NACOM. Patient was hospitalized. Patient recovered.